Author

Susette Welm

Observed names: S WELM, S Welm

Observed institutions: Mayo Clinic, University of California, San Francisco, Langley Porter Psychiatric Hospital and Clinics, University of California San Francisco Medical Center, Mayo Clinic in Arizona

OpenAlex ID: A5041405490

Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial

2000 · Steven J. Lester, Matthew Baggott, et al. · Annals of Internal Medicine · 137

Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine

2000 · Debra S Harris, Reese T Jones, et al. · Drug and Alcohol Dependence · 131

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

1999 · J. Mendelson, Reese T. Jones, et al. · Psychopharmacology · 102

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

1996 · John Mendelson, Reese T. Jones, et al. · Clinical Pharmacology & Therapeutics · 79

Buprenorphine and naloxone interactions in methadone maintenance patients

1997 · John Mendelson, Reese T. Jones, et al. · Biological Psychiatry · 55

Improved performance 4 hours after cocaine

1993 · Richard Stillman, Reese T. Jones, et al. · Psychopharmacology · 35

Dose proportionality of 4, 8, 16 and 32 mg sublingual buprenorphine solutions1

1999 · J MENDELSON, R UPTON, et al. · Clinical Pharmacology & Therapeutics · 3

Cardiovascular effects of 3,4-methylenedioxymethamphetamine: a double-blind, placebo-controlled trial

2001 · S.J Lester, M Baggott, et al. · ACC Current Journal Review

Works count: 8

Citation count: 542

H-index: 6

I10-index: 6